| MEDPACE HOLDINGS DL-,01 |
| USA |
| Gesundheit |
| US58506Q1094 / A2APTV |
| 01P (Frankfurt) / MEDP (NASDAQ) |
| FRA:01P, ETR:01P, 01P:GR, NASDAQ:MEDP |
| - |
| https://www.medpace.com/ |
|
Medpace Holdings Inc. is a contract research organization that provides clinical development services for pharmaceutical, biotechnology, and medical device companies. Medpace supports the drug and device trial process across all major stages, offerin..
>Volltext.. |
| 14006.14 Mio. EUR |
| 13692.17 Mio. EUR |
| 2414.25 Mio. EUR |
| 530.35 Mio. EUR |
| 426.48 Mio. EUR |
| 15.09 EUR |
| 125.05 Mio. EUR |
| 436.19 Mio. EUR |
| 653.1 Mio. EUR |
| 0.35 |
| 28.59% |
| 21.2% |
| - |
| - |
| - |
| 2 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 7.684.994 Euro. |
| MEDPACE |
| 04.08.26 |